To this end, evasion of apoptosis is a hallmark of cancer which contributes to therapeutic resistance [18], and altered levels of various apoptosis signalling proteins have been associated with treatment responsiveness in many cancers [19]. This evidence concerns the gene PROS1 and cancer.